US Stock MarketDetailed Quotes

PLX Protalix Biotherapeutics

Watchlist
  • 3.045
  • +0.045+1.50%
Trading May 2 09:43 ET
237.61MMarket Cap76.13P/E (TTM)

About Protalix Biotherapeutics Company

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.

Company Profile

SymbolPLX
Company NameProtalix Biotherapeutics
Listing DateApr 9, 1996
Issue Price6.00
Founded1993
CEOMr. Dror Bashan
MarketAMEX
Employees213
Fiscal Year Ends12-31
Address2 University Plaza,Suite 100
CityHackensack
ProvinceNew Jersey
CountryUnited States of America
Zip Code07601
Phone1-201-696-9345
Websitehttp://www.protalix.com

Company Executives

  • Name
  • Position
  • Salary
  • Dror Bashan
  • Director, President and Chief Executive Officer
  • 2.68M
  • Eyal Rubin
  • Senior Vice President, Chief Financial Officer, Treasurer, Secretary and Principal Accounting Officer
  • 1.03M
  • Yaron Naos
  • Senior Vice President, Operations
  • 776.37K
  • Dr. Eliot Richard Forster, M.B.A.,PhD
  • Chairman of the Board
  • 47.99K
  • Gwen A. Melincoff
  • Independent Director
  • 79.91K
  • Amos Bar Shalev
  • Independent Director
  • 79.91K
  • Dr. Shmuel Ben-Zvi, PhD
  • Independent Director
  • 74.71K
  • Dr. Pol F. Boudes,M.D.
  • Independent Director
  • 115.39K
  • Dr. Aharon Schwartz,PhD
  • Independent Director
  • 79.91K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
DexCom
DXCM
78.830
New Fortress Energy
NFE
5.910
Hutchmed (China)
HCM
15.360
4
Halozyme Therapeutics
HALO
61.680
5
YETI Holdings
YETI
28.940
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.